RE-BVS – Piemonte Repository

Sfoglia per AUTORE
HAUSCHILD A
Collezione AOU Città della Salute di Torino

Items : 2

Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Oct 18;158:156-168. doi: 10.1016/j.ejca.2021.09.023.

2021
AOU Città della Salute di Torino

Eggermont AM; Meshcheryakov A; Atkinson V; Blank CU; Mandala M; Long GV; Barrow C; Di Giacomo AM; Fisher R; Sandhu S; Kudchadkar R; Ortiz Romero PL; Svane IM; Larkin J; Puig S; Hersey P; Quaglino P; Queirolo P; Stroyakovskiy D; Bastholt L; Mohr P; Hernberg M; Chiarion-Sileni V; Strother M; Hauschild A; Yamazaki N; van Akkooi AC; Lorigan P; Krepler C; et alii...

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015. in Journal of translational medicine / J Transl Med. 2016 Jul 25;14(1):65. doi: 10.1186/s12967-016-0791-2.

2016
AOU Città della Salute di Torino

Nanda VGY; Peng W; Hwu P; Davies MA; Ciliberto G; Fattore L; Malpicci D; Aurisicchio L; Ascierto PA; Croce CM; Mancini R; Spranger S; Gajewski TF; Wang Y; Ferrone S; Vanpouille-Box C; Wennerberg E; Pilones KA; Formenti SC; Demaria S; Tang H; Wang Y; Fu YX; Dummer R; Puzanov I; Tarhini A; Chauvin JM; Pagliano O; Fourcade J; et alii...